After five half-lives (25 days), approximately 3.1% of the last dose remains in circulation
Supports removal of melanin laden dead skin cells*
It produced the highest weight loss seen in any phase 2 trial, up to 24% at the highest dose
Here, we defined a novel NRF2 target gene set linked to NRF2-dependency in cancer cell lines, and observed that a significant portion of these genes is devoid of promoter-proximal NRF2 occupancy
Taken together, these results reveal that aminoglycosides and fluoroquinolones can induce cytoplasmic condensation and lysis through membrane damage, and, as suggested by SYTOX Blue, this membrane damage coincides with loss of cell viability
For general wellness and energy support, B12 injections are typically given every two to three weeks